Investment Summary

Lincoln Park Capital Exits rMark Bio

On April 4, 2021, invested in information technology company rMark Bio from Lincoln Park Capital

Investment Highlights
  • This is transaction in the Information Technology sector.
  • This is transaction in the United States.
  • This is transaction in Illinois.
Investment Fate
  • rMark Bio was sold to a strategic buyer in 2021.

Investment Summary

Date 2021-04-04
Target rMark Bio
Sector Information Technology
Sellers(s) Lincoln Park Capital
Deal Type Trade Sale

Target

rMark Bio

Chicago, Illinois, United States
rMark Bio provides AI solutions to track real-time business strategies of R&D, Medical Affairs, Marketing, and Commercial fields to the pharmaceutical industry. rMark Bio was founded in 2015 and is based in Chicago, Illinois.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Seller(S) 1

DESCRIPTION

Lincoln Park Capital LLC is an asset management firm focused on investing in public and private companies, real estate, and other strategies. Lincoln Park Capital looks to invest up to $5 million per transaction. Prospective transaction situations include management buyouts and growth financings. Lincoln Park Capital was formed in 2010 and is based in Chicago, Illinois.


DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Trade Sale M&A Deals 1 of 1
State: Illinois M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-02-07 rMark Bio

Chicago, Illinois, United States

rMark Bio provides AI solutions to track real-time business strategies of R&D, Medical Affairs, Marketing, and Commercial fields to the pharmaceutical industry. rMark Bio was founded in 2015 and is based in Chicago, Illinois.

Buy -